Main Article Content

Abstract

Hepatitis is a disorder in liver inflammation that can be caused by infection with parasites, protozoa, bacteria, viruses, metabolic disorders, drugs, and alcohol that causes damage to human liver cells and can attack all ages, genders, and races throughout the world. Serum Glutamic Oxaloacetic Transaminase (SGOT) and Serum Glutamic Pyruvic Transaminase (SGPT) levels in EDTA plasma can tend to increase more than serum. It is because EDTA plasma contains coagulation factors that can interfere with examining SGOT and SGPT levels on the device. In contrast, serum consists of proteins, electrolytes, antibodies, antigens, and hormones that do not contain coagulation factors. This study aims to compare SGOT and SGPT levels on serum and EDTA plasma samples in Hepatitis B patients. This type of research is an experimental study. This research was conducted on 35 hepatitis B specimens and then tested using the enzymatic method with Humastar 100 (spectrophotometry). Abnormal SGOT levels (>27 U/L) were 54.3% in serum and 51.4% in plasma EDTA. Abnormal SGPT levels (>34 U/L) were 22.9% in serum and 25.7% in plasma EDTA, so there is an insignificant difference in SGOT and SGPT levels in EDTA serum and plasma samples.

Keywords

EDTA Plasma Hepatitis B serum erum Glutamic Oxaloacetic Transaminase-SGOT Serum Glutamic Pyruvic Transaminase-SGPT

Article Details

How to Cite
Khairani, N., Kurniawan, M., & Dewi, A. (2022). Differences of SGOT-SGPT Levels in Serum and EDTA Plasma in Hepatitis B Patients. Jurnal Ilmu Dan Teknologi Kesehatan, 9(2), 253-260. https://doi.org/10.32668/jitek.v9i2.759

References

    AbdelAziz, A. et al. (2018) ‘Molecular Evaluation of Midikine (Mdk) As A Potential Biomarker Todetect Hepatocellular Carcinoma’, Research Journal of Applied Biotechnology, 4(1), pp. 66–76. doi: https://dx.doi.org/10.21608/rjab.2018.57518.

    Badan Penelitian dan Pengembangan Kesehatan (2013) Riset kesehatan dasar 2013. Jakarta. Available at: http://labdata.litbang.kemkes.go.id/images/download/laporan/RKD/2013/Laporan_riskesdas_2013_final.pdf.

    Collinson, P. O. and Gaze, D. C. (2007) ‘Biomarkers of cardiovascular damage and dysfunction—an overview’, Heart, Lung and Circulation, 16(3), pp. S71–S82. doi: https://doi.org/10.1016/j.hlc.2007.05.006.

    Fanani, D. N. (2018) Gambaran Enzim Sgot Dan Sgpt Pada Pasien Hepatitis B Di Laboratorium Klinika Surabaya Periode 2017. Universitas Airlangga. Available at: https://repository.unair.ac.id/79136/.

    Ghorbani, P. et al. (2019) ‘Upregulation of single nucleotide polymorphism of PD-1 gene (rs10204525) in chronic hepatitis B patients’, Int. Arch. Med. Microbiol, 2(1), pp. 1–8. doi: https://doi.org/10.23937/2643-4008/1710009.

    Kementerian Kesehatan RI (2014) ‘Situasi dan analisis hepatitis’. Jakarta: Pusat Data dan Informasi Kementerian Kesehatan RI. Available at: https://pusdatin.kemkes.go.id/download.php?file=download/pusdatin/infodatin/infodatin-hepatitis.pdf.

    Maulidia, V. N. R. (2019) Kadar Sgot, Sgpt, Dan Albumin Pada Pasien Dengan Hepatitis B Kronis Di Rsud Dr. Soetomo Surabaya (Penelitian Analitik Cross-Sectional). Universitas Airlangga. Available at: https://repository.unair.ac.id/93561/.

    Mohri, M. and Rezapoor, H. (2009) ‘Effects of heparin, citrate, and EDTA on plasma biochemistry of sheep: comparison with serum’, Research in Veterinary Science, 86(1), pp. 111–114. doi: https://doi.org/10.1016/j.rvsc.2008.05.010.

    Nispahayati, N., Agrijanti, A. and Getas, I. W. (2019) ‘Hasil Pemeriksaan Serum Glutamik Oksaloasetik Transaminase (Sgot) Dan Serum Glutamik Pyruvik Transaminase (Sgpt) Pada Pasien Dengan Hasil Hbsag Positif Di Rsud Praya’, Jurnal Analis Medika Biosains (JAMBS), 5(1), pp. 21–24. doi: https://doi.org/10.32807/jambs.v5i1.99.

    Panjaitan, T. M. et al. (2021) ‘The Hepatoprotective Effect of White Turmeric Ethanol Extract on Cyclophosphamide-Induced Male Wistar Rats’, in 2021 IEEE International Conference on Health, Instrumentation & Measurement, and Natural Sciences (InHeNce). IEEE, pp. 1–5. doi: https://doi.org/10.1109/InHeNce52833.2021.9537254.

    Parvez, M. K. et al. (2019) ‘The in vitro and in vivo anti-hepatotoxic, anti-hepatitis B virus and hepatic CYP450 modulating potential of Cyperus rotundus’, Saudi Pharmaceutical Journal, 27(4), pp. 558–564. doi: https://doi.org/10.1016/j.jsps.2019.02.003.

    Patel, J. B. et al. (2017) Performance standards for antimicrobial susceptibility testing. 29th edn. Pennsylvania: Clinical and laboratory standards institute. Available at: https://clsi.org/media/2663/m100ed29_sample.pdf.

    Rizky, V. and Wulan, W. S. (2019) ‘Pengaruh Waktu Penanganan Pemeriksaan Terhadap Kadar SGPT pada Serum dan Plasma EDTA’, Analis Kesehatan Sains, 8(2), pp. 777–781. Available at: http://journal.poltekkesdepkes-sby.ac.id/index.php/ANKES/article/view/1212.

    Setiawan, M. (2020) Angka Kejadian Hepatitis pada Pasien yang Menjalani Hemodialisa di RS. Dr. Wahidin Sudirohusodo Periode Januari-Juni 2019. Universitas Hasanuddin. Available at: http://repository.unhas.ac.id/id/eprint/1650/.

    Suburban, L. (2019) Cirrhosis is a chronic. Naperville: Gastroenterology, Ltd. Available at: https://www.sgihealth.com/patients/digestive-health-library/cirrhosis/.

    Yu, Z. et al. (2011) ‘Differences between human plasma and serum metabolite profiles’, PloS one, 6(7), p. e21230. doi: https://doi.org/10.1371/journal.pone.0021230.